WARTAKOTALIVE, JAKARTA – The Ministry of Health has not decided to remove the drug Azithromisin and Oseltamivir for the standard of care for Covid-19 patients.
Spokesperson for the Covid-19 vaccination of the Ministry of Health, Dr. Siti Nadia Tarmizi MEpid, said that his party was still reviewing revisions from a number of professional organizations related to the Covid-19 protocol.
“Not yet (deleted).”
“We have received the recommendation, but we are still discussing it further,” he said when confirmed, Tuesday (20/7/2021).
Thus, the use of the two drugs can still be continued, provided that the supervision of health workers is needed.
“While still using the previous guidelines. So it is still safe to use,” explained this woman wearing a hijab.
Previously, experts from the Indonesian Doctors Association (IDI) Prof Zubairi Djoerban said, revision of usage Oseltamivir and Azithromisin WHO also carried out for Covid-19 patients.
Oseltamivir is an antiviral drug, which is used to treat Influenza infections in the body.
“Not for Covid-19.”
Also read: Eid al-Adha, Rizieq Shihab Sacrifice a Cow for Gaza Palestinians
“So it’s clear, in principle, Oseltamivir That is not Covid-19 medicine,” he said as quoted from his Twitter account, Monday (19/7/2021).
–